1α,25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer

被引:109
|
作者
Nakagawa, K
Kawaura, A
Kato, S
Takeda, E
Okano, T
机构
[1] Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan
[2] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan
[3] Univ Tokushima, Sch Med, Dept Clin Nutr, Tokushima, Japan
关键词
D O I
10.1093/carcin/bgh332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1alpha,25-Dihydroxyvitamin D-3 [1alpha,25(OH)(2)D-3], the major regulator of calcium homeostasis, has potent antiproliferative and anti-invasive properties in vitro in cancer cells. Studies in vivo demonstrated that 1alpha,25(OH)(2)D-3 slows the progression of breast, prostate and other carcinomas. A key question is whether 1alpha,25(OH)(2)D-3 exerts its anticarcinogenic effects in vivo by a mechanism that is dependent on its capacity to limit the proliferation and invasiveness of cancer cells in vitro. It has not been clear whether the calcemic activity and regulation of the host defenses by 1alpha,25(OH)(2)D-3 contribute to the effect on cancer cells. In this study we have focused on the influence of 1alpha,25(OH)(2)D-3 on the metastasis of lung cancer, without involvement of the calcemic activity and other effects of 1alpha,25(OH)(2)D-3 in the host. We used metastatic Lewis lung carcinoma cells expressing green fluorescent protein (LLC-GFP cells) and examined metastatic activity in vitamin D receptor (VDR) null mutant (VDR-/-) mice and their wild-type counterparts (VDR+/+ mice). VDR-/- mice exhibit hypocalcemia and extremely high serum levels of 1alpha,25(OH)(2)D-3. We expected that serum 1alpha,25(OH)(2)D-3 would act in vivo to directly inhibit the metastatic growth of VDR-positive LLC-GFP cells in VDR-/- mice. The metastatic activities of LLC-GFP cells were remarkably reduced in VDR-/- mice compared with VDR+/+ mice. To test the hypothesis that serum 1alpha,25(OH)(2)D-3 is an intrinsic factor that inhibits metastatic growth of lung cancer cells, we corrected hypocalcemia and/or hypervitaminosis D in VDR-/- mice by dietary manipulation. The metastatic growth of LLC-GFP cells was remarkably reduced in response to serum levels of 1alpha,25(OH)(2)D-3, but not to serum calcium levels. Furthermore, we found that VDR+/+ mice fed the manipulated diets displayed an apparent inverse relationship between the physiological levels of serum 1alpha,25(OH)(2)D-3 (8-15 pg/ml) and tumorigenesis. Here we show that 1alpha,25(OH)(2)D-3 inhibits the metastatic growth of lung cancer cells in a defined animal model.
引用
收藏
页码:429 / 440
页数:12
相关论文
共 50 条
  • [1] 22-oxa-1α,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer
    Nakagawa, K
    Sasaki, Y
    Kato, S
    Kubodera, N
    Okano, T
    CARCINOGENESIS, 2005, 26 (06) : 1044 - 1054
  • [2] Apoptosis induction by 1α,25-dihydroxyvitamin D3 in prostate cancer
    Guzey, M
    Kitada, S
    Reed, JC
    MOLECULAR CANCER THERAPEUTICS, 2002, 1 (09) : 667 - 677
  • [3] Nongenomic effects of 1α,25-dihydroxyvitamin D3
    Revelli, A
    Massobrio, M
    Tesarik, J
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1998, 9 (10): : 419 - 427
  • [4] Primary Human Osteoblasts in Response to 25-Hydroxyvitamin D3, 1,25-Dihydroxyvitamin D3 and 24R, 25-Dihydroxyvitamin D3
    van der Meijden, Karen
    Lips, Paul
    van Driel, Marjolein
    Heijboer, Annemieke C.
    Schulten, Engelbert A. J. M.
    den Heijer, Martin
    Bravenboer, Nathalie
    PLOS ONE, 2014, 9 (10):
  • [5] Effects of 1α,25-dihydroxyvitamin D3 in human colon cancer cells
    Gonzalez-Sancho, Jose Manuel
    Larriba, Maria Jesus
    Ordonez-Moran, Paloma
    Palmer, Hector G.
    Munoz, Alberto
    ANTICANCER RESEARCH, 2006, 26 (4A) : 2669 - 2681
  • [6] Characterization of 3-epi-1α,25-dihydroxyvitamin D3 involved in 1α,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines
    Masuda, S
    Kamao, M
    Schroeder, NJ
    Makin, HLJ
    Jones, G
    Kremer, R
    Rhim, J
    Okano, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (02) : 133 - 139
  • [7] 1α,25-dihydroxyvitamin D3 -: Not just a calciotropic hormone
    Kumar, R
    NEPHRON, 2002, 91 (04) : 576 - 581
  • [8] Analogs of 1α′25-dihydroxyvitamin D3 as pluripotent Immunomodulators
    van Etten, E
    Decallonne, B
    Verlinden, L
    Verstuyf, A
    Bouillon, R
    Mathieu, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (02) : 223 - 226
  • [9] Analogs of 1α,25-Dihydroxyvitamin D3 in Clinical Use
    DeLuca, Hector F.
    Plum, Lori A.
    VITAMIN D HORMONE, 2016, 100 : 151 - 164
  • [10] Expression of nephronectin is enhanced by 1α,25-dihydroxyvitamin D3
    Hiranuma, Katsuhiro
    Yamada, Atsushi
    Kurosawa, Tamaki
    Aizawa, Ryo
    Suzuki, Dai
    Saito, Yoshiro
    Nagahama, Ryo
    Ikehata, Mikiko
    Tsukasaki, Masayuki
    Morimura, Naoko
    Chikazu, Daichi
    Maki, Koutaro
    Shirota, Tatsuo
    Takami, Masamichi
    Yamamoto, Matsuo
    Iijima, Takehiko
    Kamijo, Ryutaro
    FEBS OPEN BIO, 2016, 6 (09): : 914 - 918